Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Occupational Heat-Health Warning System for Europe: The HEAT-SHIELD Platform.
Morabito M, Messeri A, Noti P, Casanueva A, Crisci A, Kotlarski S, Orlandini S, Schwierz C, Spirig C, Kingma BRM, Flouris AD, Nybo L. Morabito M, et al. Among authors: spirig c. Int J Environ Res Public Health. 2019 Aug 13;16(16):2890. doi: 10.3390/ijerph16162890. Int J Environ Res Public Health. 2019. PMID: 31412559 Free PMC article.
Overview of Existing Heat-Health Warning Systems in Europe.
Casanueva A, Burgstall A, Kotlarski S, Messeri A, Morabito M, Flouris AD, Nybo L, Spirig C, Schwierz C. Casanueva A, et al. Among authors: spirig c. Int J Environ Res Public Health. 2019 Jul 25;16(15):2657. doi: 10.3390/ijerph16152657. Int J Environ Res Public Health. 2019. PMID: 31349585 Free PMC article. Review.
The HEAT-SHIELD project - Perspectives from an inter-sectoral approach to occupational heat stress.
Morris NB, Piil JF, Morabito M, Messeri A, Levi M, Ioannou LG, Ciuha U, Pogačar T, Kajfež Bogataj L, Kingma B, Casanueva A, Kotlarski S, Spirig C, Foster J, Havenith G, Sotto Mayor T, Flouris AD, Nybo L. Morris NB, et al. Among authors: spirig c. J Sci Med Sport. 2021 Aug;24(8):747-755. doi: 10.1016/j.jsams.2021.03.001. Epub 2021 Mar 8. J Sci Med Sport. 2021. PMID: 33757698 Review.
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, Cappuzzo F, Besse B, Thiberville L, Rouvière D, Dziadziuszko R, Smit EF, Wolf J, Spirig C, Pecuchet N, Leenders F, Heuckmann JM, Diebold J, Milia JD, Thomas RK, Gautschi O. Mazières J, et al. Among authors: spirig c. J Clin Oncol. 2015 Mar 20;33(9):992-9. doi: 10.1200/JCO.2014.58.3302. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667280
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06).
Rochlitz C, Ruhstaller T, Lerch S, Spirig C, Huober J, Suter T, Bühlmann M, Fehr M, Schönenberger A, von Moos R, Winterhalder R, Rauch D, Müller A, Mannhart-Harms M, Herrmann R, Cliffe B, Mayer M, Zaman K; Swiss Group for Clinical Cancer Research (SAKK). Rochlitz C, et al. Among authors: spirig c. Ann Oncol. 2011 Jan;22(1):80-85. doi: 10.1093/annonc/mdq319. Epub 2010 Jul 1. Ann Oncol. 2011. PMID: 20595448 Free article. Clinical Trial.
15 results